What is ArriVent BioPharma, Inc.'s return on invested capital?

ArriVent BioPharma, Inc. (AVBP) reported return on invested capital of -75.6% in Q1 2026.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.

ArriVent BioPharma, Inc. AVBP Return on invested capital

Return on invested capital at other companies

Johnson & JohnsonJNJ

20.6%+0.3pp

Syndax PharmaceuticalsSNDX

-67.9%-12.9pp

Nuvation BioNUVB

-47.4%-18.6pp

ImmunomeIMNM

-746.6%+212pp

Arcus BiosciencesRCUS

-95.3%+1.8pp

Erasca, Inc.ERAS

-75.9%+17.2pp

Other financials

Income statement

See full

Operating income-$46.1M+30.9%

Net income-$43.3M+32.7%

EPS (diluted)-$0.96+49.5%

Balance sheet

See full

Cash & equivalents$62.1M+24.5%

Total debt$419.0K+204%

Total equity$324.0M+60.0%

Total assets$349.3M+62.1%

Cash flow

See full

Operating cash flow-$41.9M+38.4%

Valuation

See full

Market cap$1.57B+62.1%

Enterprise value$1.51B+65.4%

Returns & leverage

See full

Return on equity-55.2%+8.0pp

Debt / equity0×0.0×

Current ratio14×-0.4×

Where this comes from

Calculated from ArriVent BioPharma, Inc.’s reported figures.

nopat/invested capital=-75.6%

Based on trailing twelve months.

The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about ArriVent BioPharma, Inc.'s return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ArriVent BioPharma, Inc.'s return on invested capital?: ArriVent BioPharma, Inc. (AVBP) reported return on invested capital of -75.6% in Q1 2026.
What does return on invested capital mean?: Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.